A Universal Formulary
Author : Robert Eglesfeld Griffith
Publisher :
Page : 618 pages
File Size : 15,1 MB
Release : 1850
Category : Medicine
ISBN :
Author : Robert Eglesfeld Griffith
Publisher :
Page : 618 pages
File Size : 15,1 MB
Release : 1850
Category : Medicine
ISBN :
Author : Robert Eglesfeld Griffith
Publisher :
Page : 618 pages
File Size : 49,88 MB
Release : 1850
Category : Drugs
ISBN :
Author : C. Terrance Hawk
Publisher : Wiley-Blackwell
Page : 203 pages
File Size : 43,89 MB
Release : 2005-01-24
Category : Medical
ISBN : 9780813810485
Formulary for Laboratory Animals is an invaluable reference for treatment of laboratory animals and pocket pets. Drugs are listed alphabetically and categorized in five sections based on pharmacologic activity and animal species. This at-a-glance pocket reference is valuable for students and practitioners of veterinary medicine, researchers and laboratory technicians who prescribe or administer drugs used on common laboratory animals. The third edition includes a stronger international component, coverage of several new drugs, hundreds of additional dosages, and a thorough update throughout based on the most current research. The third edition also includes a chapter describing how to estimate drug dosages among species using allometric scaling methodology.
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 235 pages
File Size : 16,48 MB
Release : 2018-03-01
Category : Medical
ISBN : 0309468086
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author : Institute of Medicine
Publisher : National Academies Press
Page : 280 pages
File Size : 39,66 MB
Release : 2000-10-03
Category : Medical
ISBN : 0309183537
The VA National Formulary generated controversy, which motivated congressional scrutiny and a directive to the VA to commission this report reviewing the experience with the National Formulary and formulary system. This Institute of Medicine committee was pleased to assist the Congress with this review, in part because the committee saw in the VHA example an opportunity to understand and anticipate problems that all publicly funded programs are likely to encounter in this new age of pharmaceuticals. The Congress asked the committee to review the restrictiveness of the National Formulary, its impact on the costs and quality of care in the VHA, and how it compared to formularies and drug management practices in the private sector and in other public programs, especially Medicaid. Detailed in the pages that follow, the committee's findings and conclusions on these questions are, the committee believes, highly instructive, though not always in the ways that we anticipated.
Author : New Hampshire Pharmaceutical Association
Publisher :
Page : 718 pages
File Size : 35,66 MB
Release : 1886
Category : Pharmacy
ISBN :
Vols. for -1905 include Report of Commission of Pharmacy.
Author :
Publisher :
Page : 692 pages
File Size : 45,79 MB
Release : 1879
Category :
ISBN :
Author : Charles Delucena Meigs
Publisher :
Page : 250 pages
File Size : 27,18 MB
Release : 1850
Category : Autographs
ISBN :
Author :
Publisher :
Page : 426 pages
File Size : 22,6 MB
Release : 1850
Category : Pharmacy
ISBN :
Author : Joseph-François Malgaigne
Publisher :
Page : 602 pages
File Size : 35,44 MB
Release : 1851
Category : Surgery, Operative
ISBN :